Skip to main content
logo
Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
10.73
-0.37 (-3.33%)
At close: Jul 24, 2026, 4:00 PM EDT
11.00
+0.27 (2.52%)
Pre-market: Jul 27, 2026, 8:06 AM EDT

Intellia Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-394.6-412.69-519.02-481.19-474.19-267.89
Depreciation & Amortization
9.479.7710.298.987.576.89
Stock-Based Compensation
71.8680.22154.27134.0591.447.01
Other Adjustments
-4.441.72-6.3-3.4795.811.87
Change in Receivables
1.37-0.9527.94-32.69-1.740.1
Changes in Accounts Payable
6.445.996.82.52-4.580.53
Changes in Accrued Expenses
-2.8-5.27-10.386.0215.9217.26
Changes in Unearned Revenue
-29.68-28.11-22.08-2.78-63.46-31.36
Changes in Other Operating Activities
-27.46-45.419.6-25.53-0.01-9.44
Operating Cash Flow
-363.15-394.74-348.88-394.09-333.29-225.03
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.47-1.13-5.78-13.99-13.56-12.76
Sale of Property, Plant & Equipment
----0.15-
Purchases of Investments
-286.27-322.51-935.57-904.46-429.03-1,021
Proceeds from Sale of Investments
486.75551.671,067887.1647.58485.6
Cash Acquisitions
-----44.83-
Other Investing Activities
------3
Investing Cash Flow
200.01228.03125.57-31.35160.31-550.78

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
161.74131.49185.75130.32582.96736.69
Net Common Stock Issued (Repurchased)
161.74131.49185.75130.32582.96736.69
Financing Cash Flow
165.06131.49185.75130.32582.96736.69

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
1.92-35.22-37.57-295.11409.98-39.12

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-363.63-395.87-354.66-408.07-346.85-237.79
Free Cash Flow Growth
------
FCF Margin
-550.18%-584.99%-612.78%-1124.94%-665.46%-719.41%
Free Cash Flow Per Share
-3.24-3.65-3.59-4.60-4.51-3.35
Levered Free Cash Flow
-439.1-476.86-530.58-505.97-532.31-296.76
Unlevered Free Cash Flow
-465.22-505.15-545.82-540.06-516.29-296.72
SEC Filings: 10-K · 10-Q